首页/股票/RLMD

RLMD

USD

Relmada Therapeutics Inc. Common Stock

$2.770+0.560 (25.339%)

实时价格

Healthcare

生物技术

美国

价格图表

Loading Chart...

关键指标

市场指标

公司基本面

交易统计

市场指标

开盘价

$2.210

最高价

$2.810

最低价

$2.190

成交量

0.98M

公司基本面

市值

91.9M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.74M

交易所

NCM

货币

USD

52周价格范围

最低价 $0.24当前价 $2.770最高价 $3.5

相关新闻

2025年11月4日 · 12:09

GlobeNewswire

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

2025年11月4日 · 12:01

GlobeNewswire

Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer

Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized